Transparency in Industry Partnerships: Building...

By HEOR Staff Writer

June 25, 2025

This update emphasizes transparency in industry partnerships as essential for building trust and prioritizing patient care. It highlights EFPIA’s mandatory disclosure requirements for financial interactions with healthcare professionals (HCPs) and...
DALY Modeling Methods for Enhanced Health Economics and Policy Analysis
Pharmaceutical Pricing Issues: Beyond Overpricing and Profit Motives
FDA Approval and Access Strategy for Lenacapavir (Yeztugo) Long-Acting HIV Pr...
Canada Launches Consultation for Essential Prescription Drugs List
EMA 2024 Report Highlights: Innovations in Medicine Approval and Regulatory A...
NICE Approves Transformative Multiple Myeloma Treatment
Telemedicine Growth Strategies: Insights from the WHO European Region
Future-Proofing Hospitals: Singapore’s Blueprint for Smarter Healthcare
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
Elsa – FDA AI Tool: Navigating Efficiency and Ethics
What are the Plans and Implications for Keytruda´s Biosimilar
The Case for Transparency in Peer Review: Enhancing Scientific Integrity and ...